To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
VC-backed C4 Therapeutics goes public
C4 Therapeutics, a biopharmaceutical company, has raised $182.4 million for its IPO after pricing its 9.6 million shares at $19 per share.
